NASDAQ:EIKN | Free Cash Flow | Eikon Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$89.8M$262,000.00-$90.06M
2025-03-31-$54.52M$22.36M-$76.88M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income